Tumor Biology

, Volume 36, Issue 6, pp 4017–4025 | Cite as

The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses

  • Xiaoyun Ding
  • Xiangxiang Wan
  • Haizhong Jiang
  • Haojun Song
  • Ying Fang
  • Shengcan Chen
  • Peifei Li
  • Junming Guo



This study was funded by the Natural Science Foundation of Ningbo (Nos. 2013A610218, 2011A610056, and 2014A610226) and the Scientific Benefit for People Project of Ningbo (No. 2014C51001).

Conflicts of interest


Supplementary material

13277_2015_3411_MOESM1_ESM.doc (760 kb)
ESM 1 Figs. S1.1–1.8 Figures of meta-analysis of clinicopathological features. Figs. S2.1–2.3 Figures of diagnostic meta-analysis. Figs. S3.1–3.7 Figures of prognostic meta-analysis (DOC 760 kb)
13277_2015_3411_MOESM2_ESM.xls (95 kb)
ESM 2 Table S1 Characteristics of studies included in the review of clinicopathological features. Table S2 Characteristics of studies included in the diagnosis of GC. Table S3 Characteristics of studies included in the prognosis of GC (XLS 95 kb)
13277_2015_3411_MOESM3_ESM.docx (23 kb)
ESM 3 Reference S1 The references for supplementary Table S1 (DOCX 23 kb)
13277_2015_3411_MOESM4_ESM.docx (115 kb)
ESM 4 Reference S2 The references for supplementary Tables 2 and 3 (DOCX 115 kb)


  1. 1.
    Li L, Sheng Y, Lv L, Gao J. The association between two microRNA variants (miR-499, miR-149) and gastrointestinal cancer risk: a meta-analysis. PLoS One. 2013;8, e81967.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Xu Y, Sun J, Xu J, Li Q, Guo Y, Zhang Q. miR-21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. Gastroenterol Res Pract. 2012;2012:640168.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35–47.CrossRefPubMedGoogle Scholar
  4. 4.
    Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847–65.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wang Z, Cai Q, Jiang Z, Liu B, Zhu ZG. Prognostic role of microRNA-21 in gastric cancer: a meta-analysis. Med Sci Monit. 2014;20:1668–74.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, Nagata H, et al. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res. 2013;33:271–6.PubMedGoogle Scholar
  7. 7.
    Liu D, Sun Q, Liang S, Xu L, Luo X, Zhao X, et al. MicroRNA-27a inhibitors alone or in combination with perifosine suppress the growth of gastric cancer cells. Mol Med Rep. 2013;7:642–8.PubMedGoogle Scholar
  8. 8.
    Kurashige J, Mima K, Sawada G, Takahashi Y, Eguchi H, Sugimachi K, et al. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Carcinogenesis. 2015;36:133–41.CrossRefPubMedGoogle Scholar
  9. 9.
    Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. 2013;19:5602–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Wang M, Li C, Yu B, Su L, Li J, Ju J, et al. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol. 2013;48:1023–33.CrossRefPubMedGoogle Scholar
  11. 11.
    Xu XD, He XJ, Tao HQ, Zhang W, Wang YY, Ye ZY, et al. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. J Surg Oncol. 2013;108:197–202.CrossRefPubMedGoogle Scholar
  12. 12.
    Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9:587–97.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J, et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene. 2014;33:193–202.CrossRefPubMedGoogle Scholar
  14. 14.
    Wang Z, Ma X, Cai Q, Wang X, Yu B, Liu B, et al. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 2014;588:4504–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, et al. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol. 2013;20 Suppl 3:S397–405.CrossRefPubMedGoogle Scholar
  16. 16.
    Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. J Surg Oncol. 2012;19 Suppl 3:S656–64.CrossRefGoogle Scholar
  17. 17.
    Zeng Z, Wang J, Zhao L, Hu P, Zhang H, Tang X, et al. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis. PLoS One. 2013;8, e73278.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One. 2012;7, e41629.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Diaz P, Lorenzo-Patino MJ, Haz M, et al. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med. 2012;10:186.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci. 2014;15:4031–48.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem. 2011;44:1050–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013;33:3185–93.PubMedGoogle Scholar
  23. 23.
    Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H, et al. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer. 2013;109:2323–30.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 2012;106:740–7.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49:604–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, et al. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One. 2014;9, e85205.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, et al. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res. 2013;32:76.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP, Zhang LF, et al. Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J Gastroenterol. 2011;17:3645–51.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Zhu Y-M. Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol. 2010;16:3325.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, et al. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep. 2014;31:1863–70.PubMedGoogle Scholar
  31. 31.
    Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, et al. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012;7, e40037.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 2011;22:2257–66.CrossRefPubMedGoogle Scholar
  33. 33.
    Omura T, Shimada Y, Nagata T, Okumura T, Fukuoka J, Yamagishi F, et al. Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy. Oncol Rep. 2014;31:613–8.PubMedGoogle Scholar
  34. 34.
    Zheng Y, Cui L, Sun W, Zhou H, Yuan X, Huo M, et al. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark: Sec Dis Markers. 2011;10:71–7.CrossRefGoogle Scholar
  35. 35.
    Wang B, Zhang Q. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol. 2012;138:1659–66.CrossRefPubMedGoogle Scholar
  36. 36.
    Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110:2291–9.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med. 2010;88:709–17.CrossRefPubMedGoogle Scholar
  38. 38.
    Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Osawa S, Shimada Y, Sekine S, Okumura T, Nagata T, Fukuoka J, et al. MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett. 2011;2:613–9.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep. 2012;5:1514–20.PubMedGoogle Scholar
  41. 41.
    Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, et al. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2014;105:228–35.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Wang Y, Feng X, Jia R, Liu G, Zhang M, Fan D, et al. Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. Mol Genet Genom. 2014;289:291–302.CrossRefGoogle Scholar
  43. 43.
    Zhang EB, Han L, Yin DD, Kong R, De W, Chen J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31:914.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Xiaoyun Ding
    • 1
  • Xiangxiang Wan
    • 2
  • Haizhong Jiang
    • 1
  • Haojun Song
    • 1
  • Ying Fang
    • 1
  • Shengcan Chen
    • 2
  • Peifei Li
    • 2
  • Junming Guo
    • 2
  1. 1.Department of GastroenterologyNingbo First HospitalNingboChina
  2. 2.Department of Biochemistry and Molecular Biology, Zhejiang Provincial Key Laboratory of PathophysiologyNingbo University School of MedicineNingboChina

Personalised recommendations